Ask The Expert: Focusing on the Liver: Treatment Approaches in Metastatic Uveal Melanoma

When uveal melanoma spreads, it most often affects the liver. In this webinar, we’ll explore how doctors are targeting the liver with specialized treatments and what new options are being developed to treat the whole body. We’ll also discuss the first FDA-approved therapy for this rare cancer and what’s on the horizon in clinical trials. Whether you’re newly diagnosed or navigating ongoing care, this session will help you better understand the treatment landscape and what it means for you and your loved ones.   Presented by Vincent T. Ma, MD from the University of Wisconsin in Madison and Patient Advocate Paul Lynch.  

Dr. Vincent Ma is an Assistant Professor, Medical Oncologist, in the Department of Medicine, Division of Hematology, Medical Oncology and Palliative Care; and a faculty affiliate in the Department of Dermatology at the University of Wisconsin in Madison. He is currently the Immuno-Oncology Therapeutics Director of the Early Phase Oncology Therapeutics Program at UW and the Faculty Leader of Advanced Non-Melanoma Skin Cancer at the UW Carbone Cancer Center. He also serves as co-chair of the Big Ten Cancer Research Consortium Melanoma/Cutaneous Oncology Clinical Trial Working Group.    

Dr. Ma’s primary clinical interests are the diagnosis, treatment, and surveillance of melanoma and other advanced stage cutaneous malignancies, including Merkel cell carcinoma, basal cell carcinoma, and cutaneous squamous cell carcinoma. Dr. Ma’s research focus in on biomarkers and optimizing therapeutic strategies in melanoma and other advanced skin cancers with an additional emphasis in early phase clinical trial investigation involving immunotherapy and molecular targeted therapies.    

Sponsored By Delcath